Cargando…

WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis

We have investigated the effects of WY14643, a potent peroxisome proliferator activator receptor-α (PPAR-α) agonist, in a rat model of ligature-induced periodontitis. Male Sprague-Dawley rats were lightly anaesthetized with pentobarbitone (35 mg/kg). Sterile, 2-0 black braided silk thread was placed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briguglio, Enrico, Di Paola, Rosanna, Paterniti, Irene, Mazzon, Emanuela, Oteri, Giacomo, Cordasco, Giancarlo, Cuzzocrea, Salvatore
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022213/ https://www.ncbi.nlm.nih.gov/pubmed/21253492 http://dx.doi.org/10.1155/2010/193019

Ejemplares similares

Emerging Role of PPAR-β/δ in Inflammatory Process Associated to Experimental Periodontitis
por: Di Paola, Rosanna, et al.
Publicado: (2011)

Effects of Hypericum Perforatum, in a rodent model of periodontitis
por: Paterniti, Irene, et al.
Publicado: (2010)

PPARα Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury
por: Pantazi, Eirini, et al.
Publicado: (2015)

Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes
por: Chen, Ke, et al.
Publicado: (2012)

PPARα Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-κB
por: Wen, Wanshun, et al.
Publicado: (2020)

WY14643 Increases Herpesvirus Replication and Inhibits IFNβ Production Independently of PPARα Expression
por: Tao, Lili, et al.
Publicado: (2023)

Nuclear Receptor PPARα Agonist Wy-14,643 Ameliorates Hepatic Cell Death in Hepatic IKKβ-Deficient Mice
por: Kim, Taehyeong, et al.
Publicado: (2017)

Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats
por: Karimian Azari, Elnaz, et al.
Publicado: (2013)

Chondroprotection of PPARα activation by WY14643 via autophagy involving Akt and ERK in LPS‐treated mouse chondrocytes and osteoarthritis model
por: Zhou, Yang, et al.
Publicado: (2019)

Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
por: Reddy, J. K., et al.
Publicado: (1978)

Characterization of WY 14,643 and its Complex with Aldose Reductase
por: Sawaya, Michael R., et al.
Publicado: (2016)

Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
por: Lake, B G, et al.
Publicado: (1993)

Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643
por: Wang, C, et al.
Publicado: (2004)

WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells
por: Hwang, Yong Pil, et al.
Publicado: (2019)

WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC
por: Wang, Rui, et al.
Publicado: (2022)

Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury
por: Neuhaus, Winfried, et al.
Publicado: (2017)

PPAR-α Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
por: Esposito, Emanuela, et al.
Publicado: (2010)

Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
por: Esposito, Emanuela, et al.
Publicado: (2012)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Role of PPAR-δ in the development of zymosan-induced multiple organ failure: an experiment mice study
por: Galuppo, Maria, et al.
Publicado: (2010)

Therapeutic potential of PPARα agonist in ligature-induced experimental periodontitis
por: Chen, Ying, et al.
Publicado: (2022)

The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
por: Araki, Masaya, et al.
Publicado: (2018)

Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
por: Crisafulli, Concetta, et al.
Publicado: (2010)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress
por: Sekulic-Jablanovic, Marijana, et al.
Publicado: (2017)

Role of TNF-α in lung tight junction alteration in mouse model of acute lung inflammation
por: Mazzon, Emanuela, et al.
Publicado: (2007)

Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
por: Ugwu, David I., et al.
Publicado: (2018)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
por: Reynders, Veerle, et al.
Publicado: (2006)

Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-α (PPARα)
por: Tien, Eric S., et al.
Publicado: (2006)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

Highly Selective PPARα (Peroxisome Proliferator‐Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular‐Microstructural Imaging
por: Iwata, Hiroshi, et al.
Publicado: (2021)

Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-α (PPARα) in alcoholic cardiomyopathy
por: Jing, Ling, et al.
Publicado: (2011)

Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea
por: Liang, Wentao, et al.
Publicado: (2023)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
por: Paterniti, Irene, et al.
Publicado: (2013)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
por: Tahri-Joutey, Mounia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_un6fj0a4lt4q92pt6kddfdc35n